| Pipeline | Indication | Efficacy | Pre-Clinical | Phase 1 | Phase 2 | Phase 3 |
|---|---|---|---|---|---|---|
| NovDB2 | Diabetes |
|
||||
| NovOB | Obesity |
|
||||
| NovRD | Chronic Kidney Disease |
|
||||
| NovFS | Fibrosis |
|
||||
| NovRF | Peritoneal Fibrosis |
|